Lansoprazole Metabolite A |
|
Synonyms: Lansoprazole Sulfone ; 2-[[[3-methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfonyl]-1H-benzimidazole; USP Lansoprazole Related Compound A ; EP Lansoprazole Impurity B; AG 1813 | |
Cat. No.: L11120 | CAS No.: 131926-99-3 |
MDL.: | Formula: C16H14F3N3O3S |
F.W.385.36 | Purity: 99% |
Storage: -20°C Freezer | |
  |

Catalog Number: | L11120 | CAS No.: | 131926-99-3 | |
MDL: | Formula: | C16H14F3N3O3S | ||
F.W.: | 385.36 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | White Solid | M.P.: | 207°C (dec.) | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Methanol | Stability: | ||
Storage: | -20°C Freezer | Category: | Reference Standard | |
Reference: | De Morais, S., et al.: Mol. Pharmacol., 46, 594 (1994), Spencer, C., et al.: Drugs, 48, 404 (1994), Pearce, R., et al.: J. Pharmacol. Exp. Ther., 277, 805 (1996),Tassaneeyakul, W., et al.: Br. J. Clin. Pharmacol., 49, 139 (2000), | |||
Application: | A metabolite of Lansoprazole, as gastric pump inhibitor. | |||
Category: | Heterocycles, Metabolites & Impurities, Sulfur & Selenium Compounds |